A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer
Clinical trial NCT04958993 · TERMINATED
Trial details
- NCT number
- NCT04958993
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-12
- Primary completion
- 2021-11-20
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.